Company / Depreciation & Amortization
Exelixis Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$29.1M
FY2025
5-year range
$8.3M / $29.1M
FY2021-FY2025
Trend
+0.9%
vs FY2024
Sector context
#38 of 163
Health Care
What the data says
Exelixis's depreciation & amortization of $29M is higher than 77% of companies in the Health Care sector (FY2025). Depreciation & Amortization has increased for 4 consecutive years, from $8M in FY2021 to $29M in FY2025.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of +26.0%. Top quartile in the Health Care sector.
Increased from $26M to $29M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +26.0%
- 10-Year CAGR
- -
Sector benchmark
-86.8% below sector average
Key checks
Key Insights
- Exelixis's depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +26.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 0.9% year-over-year.
- Ranks #38 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.1M | +0.9% |
| FY2024 | $28.8M | +12.0% |
| FY2023 | $25.7M | +181.3% |
| FY2022 | $9.1M | +9.5% |
| FY2021 | $8.3M | -8.7% |
| FY2020 | $9.1M | +9.5% |
| FY2019 | $8.3M | +733.1% |
| FY2018 | $1.0M | -15.6% |
| FY2017 | $1.2M | +18.5% |
| FY2016 | $1.0M | -28.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026